Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
63.40
+4.75 (8.10%)
At close: Aug 25, 2026, 4:00 PM EDT
64.51
+1.11 (1.75%)
After-hours: Aug 25, 2026, 7:52 PM EDT
Spruce Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $230 | Buy | Reiterates | $230 | +262.78% | Aug 25, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $123 → $104 | Buy | Maintains | $123 → $104 | +64.04% | Aug 17, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $140 | Buy | Maintains | $140 | +120.82% | Aug 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $160 | Buy | Initiates | $160 | +152.37% | Jul 13, 2026 |
| JonesTrading | JonesTrading | Buy Initiates $135 | Buy | Initiates | $135 | +112.93% | Jun 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $200 → $150 | Buy | Reiterates | $200 → $150 | +136.59% | Jun 1, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $140 → $120 | Buy | Reiterates | $140 → $120 | +89.27% | May 15, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $170 → $150 | Buy | Maintains | $170 → $150 | +136.59% | May 14, 2026 |